What to Expect When Starting Colchicine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Colchicine is an anti-inflammatory agent derived from the crocus plant, used to treat and prevent acute gout flares and pericarditis (inflammation around the heart). It works by disrupting the inflammatory cascade triggered by uric acid crystals. For acute gout, it is most effective when started within the first 12-24 hours of flare onset. It is also used as prophylaxis when starting urate-lowering therapy.
Week-by-week timeline
Starting for an Acute Flare
For acute gout, the modern low-dose regimen is 1.2 mg at the first sign of flare, followed by 0.6 mg one hour later (total 1.8 mg). This is as effective as high doses but much better tolerated. Start within 12-36 hours of flare onset for best results. GI side effects (nausea, diarrhea, cramping) are dose-dependent.
Flare Resolution
Joint pain, swelling, and redness should improve over 2-5 days with effective treatment. Some patients continue colchicine 0.6 mg once or twice daily until the flare fully resolves (typically 1-2 weeks total). Reduce and stop as the flare resolves.
Gout Flare Prevention
When starting allopurinol or febuxostat, colchicine 0.6 mg once or twice daily is prescribed as prophylaxis for the first 3-6 months. This prevents the paradoxical gout flares that occur as uric acid levels shift. Take consistently throughout the prophylaxis period.
Pericarditis Treatment
For pericarditis, colchicine is used alongside NSAIDs for 3-6 months to reduce recurrence. Doses are 0.5 mg twice daily (or once daily if under 70 kg). Maintaining therapy for the full course dramatically reduces recurrence risk.
Tapering and Completion
For pericarditis, colchicine is tapered based on CRP normalization and symptom resolution. Complete the prescribed course — stopping early increases recurrence risk significantly.
When to call your doctor
Contact your healthcare provider if you experience:
- Severe diarrhea, nausea, vomiting, or abdominal cramping that is severe or worsening (GI toxicity)
- Muscle pain, weakness, or dark urine (myopathy or rhabdomyolysis — especially with statin or cyclosporine combination)
- Unusual bruising or bleeding (bone marrow suppression — rare, more common with renal impairment)
- Numbness or tingling in hands or feet (neurotoxicity)
- Signs of severe allergic reaction
- Fever with decreased urine output (signs of serious toxicity)
Tips for getting started
Take colchicine at the first sign of a gout flare for the best results — early treatment is dramatically more effective than late treatment. Start within 12-24 hours of onset. Take with food to reduce GI side effects. Grapefruit juice and St. John's Wort significantly alter colchicine levels — avoid both. Many medications interact with colchicine: statins, cyclosporine, certain antibiotics, and antifungals increase colchicine toxicity risk. Always provide a full medication list to your prescriber. Patients with kidney or liver disease require dose adjustments.
Frequently asked questions
More about Colchicine
References
- [Regulatory] FDA Label: Colcrys (colchicine) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022352lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Colchicine https://medlineplus.gov/druginfo/meds/a682711.html Accessed 2026-03-01.
- [Regulatory] ACR 2020 Gout Guidelines: Colchicine Prophylaxis https://www.rheumatology.org/Practice-Quality/Clinical-Support/Clinical-Practice-Guidelines/Gout Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: